Veterinary Medicines

Troscan 500 mg film coated tablet for Dogs

Authorised
  • Nitroscanate
Download as PDF

Product identification

Medicine name:
Troscan 500 mg film coated tablet for Dogs
Troscan 500 mg film coated tablet for Dogs
Active substance:
  • Nitroscanate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Nitroscanate
    500.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AX01
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • 1. Aluminium foil strips in outer carton.or2. Aluminium foil blister containing:- Lidding foil: 20 micron hard tempered aluminium foil - one side coated with heatseal lacquer and one side primed forprinting.- Blister film: Cold formable Aluminium Bottom foil oPA/Alu/PVC - 25/45/60 micron.100 tablets (for veterinary surgeons only)
  • 1. Aluminium foil strips in outer carton.or2. Aluminium foil blister containing:- Lidding foil: 20 micron hard tempered aluminium foil - one side coated with heatseal lacquer and one side primed forprinting.- Blister film: Cold formable Aluminium Bottom foil oPA/Alu/PVC - 25/45/60 micron.60 tablets (for veterinary surgeons only)
  • 1. Aluminium foil strips in outer carton.or2. Aluminium foil blister containing:- Lidding foil: 20 micron hard tempered aluminium foil - one side coated with heatseal lacquer and one side primed forprinting.- Blister film: Cold formable Aluminium Bottom foil oPA/Alu/PVC - 25/45/60 micron.1 x 4 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10987/141/002
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0146/001
Concerned member states:
  • France

Documents

Summary of Product Characteristics

English (PDF)
Published on: 24/08/2025
Download

Combined File of all Documents

English (PDF)
Published on: 24/08/2025
Download